GDT & CAR-T Preclinical Dual Targeting & Engineering Gamma Delta Cells
Time: 4:30 pm
day: Conference Day One
Details:
- Novel set of CARs that address challenges head on for both hematological malignancy and sold tumors
- Our solid tumor program utilizes a Dual CAR architecture to target multiple cancer antigens and more completely eradicate cancerous cells with a single engineered T cell product
- Establish an allogeneic dual targeting CAR that will consist of CSPG4 and CD70
